AnGes, Inc. in brief
AnGes, Inc. is a listed company in the Biotechnology industry, based in Japan. It was founded in 1999. Its last known market value was $142 M (March 2026); there is no current figure. In the year to Dec 2020 it had sales of $0 M and a net loss of $39 M. Its shares trade under the symbol 4563.T (Tokyo).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
AnGes, Inc. timeline
- 1999
- 🏁
- 2002
- 🔔· approximateInitial public offering on Mothers as 4563
- 2008
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
Events of AnGes, Inc. from Wikidata and SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in Japan: #995 (Jan 2020) · #588 (Jan 2021) · #1,095 (Jan 2022) · #1,677 (Dec 2022) · #1,886 (Jul 2023) · #2,099 (Jan 2024) · #1,856 (Mar 2026)
Annual results
- Revenue
- $0 M
- Operating income
- —
- Net income
- $-39 M
Dec-2020 ending year
How AnGes, Inc. compares in Biotechnology
- Revenue$0 M · higher than 19% of 647
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| AnGes, Inc.🇯🇵 | $142 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Mar 8, 2026 (last known)
- Annual results:
- Dec-2020 ending year
- Balance sheet:
- Dec-2020 ending year
- Profile updated:
- Nov 15, 2026
Figures from value.today research, Wikidata.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at AnGes, Inc.? Verify and update this profile — free
Show AnGes, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.